Monsanto (NYSE:MON) EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the transaction, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Shares of Monsanto (NYSE:MON) opened at $119.70 on Friday. Monsanto has a fifty-two week low of $106.74 and a fifty-two week high of $122.79. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79. The firm has a market capitalization of $52,690.00, a PE ratio of 22.13, a PEG ratio of 1.69 and a beta of 1.04.
Monsanto (NYSE:MON) last posted its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.77 billion. During the same period in the previous year, the firm posted $0.21 earnings per share. The firm’s revenue for the quarter was up .3% on a year-over-year basis. analysts anticipate that Monsanto will post 5.79 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be issued a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.80%. The ex-dividend date is Thursday, January 4th. Monsanto’s payout ratio is currently 39.93%.
MON has been the subject of a number of recent analyst reports. Wells Fargo & Co lifted their price target on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Barclays reaffirmed an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Jefferies Group reaffirmed a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Friday, September 15th. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $126.40.
Several institutional investors have recently bought and sold shares of MON. Federated Investors Inc. PA lifted its holdings in shares of Monsanto by 0.5% in the 2nd quarter. Federated Investors Inc. PA now owns 9,555 shares of the basic materials company’s stock valued at $1,131,000 after purchasing an additional 46 shares during the last quarter. MUFG Securities EMEA plc purchased a new stake in shares of Monsanto in the 2nd quarter valued at about $13,375,000. Key Square Capital Management LLC raised its stake in Monsanto by 4.1% during the 2nd quarter. Key Square Capital Management LLC now owns 517,138 shares of the basic materials company’s stock valued at $61,208,000 after acquiring an additional 20,209 shares during the last quarter. Synovus Financial Corp raised its stake in Monsanto by 1.2% during the 2nd quarter. Synovus Financial Corp now owns 7,211 shares of the basic materials company’s stock valued at $854,000 after acquiring an additional 85 shares during the last quarter. Finally, Northwestern Mutual Investment Management Company LLC raised its stake in Monsanto by 320.1% during the 2nd quarter. Northwestern Mutual Investment Management Company LLC now owns 372,340 shares of the basic materials company’s stock valued at $38,504,000 after acquiring an additional 283,703 shares during the last quarter. 75.34% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Steven Mizell Sells 8,100 Shares of Monsanto (MON) Stock” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://ledgergazette.com/2018/01/13/steven-mizell-sells-8100-shares-of-monsanto-mon-stock.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.